Our Products
We are Bio Pharma
Leading the Way in Biosimilars, Our Expansive Portfolio Sets
Industry Standards
Papillotect
• INN: Human Papillomavirus Vaccine
• Indications: prevention of cervical cancers and precancerous lesions caused by human papillomavirus (HPV)
• Vaccine Type: VLP (virus-like particles)
• Mechanism of Action: stimulating the immune system to produce antibodies against HPV types 16 and 18
Under Registration
Flutect
• INN: Influenza Vaccine
• Indications: preventing influenza (flu) caused by specific influenza A and B viruses.
• Vaccine Type: Recombinant
• Mechanism of Action: Flutect introduces hemagglutinin (HA), a protein found on the surface of influenza viruses, to stimulate the immune system.
Under Registration
Pneumotect
• INN: Pneumococcal Vaccine
• Indications: prevent infections caused by 13 different types of Streptococcus pneumoniae bacteria, which can lead to diseases like pneumonia, meningitis, and sepsis.
• Vaccine Type: Conjugated
• Mechanism of Action: Pneumotect works by inducing an immune response against the polysaccharides (sugars) found on the surface of the 13 targeted serotypes of Streptococcus pneumoniae.
Meningotect
• INN: Meningococcal Vaccine
• Indications: prevent meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135Vaccine
• Type: Conjugated
• Mechanism of Action: Meningotect works by exposing the immune system to a harmless form of the antigens (surface proteins) found on the bacterial cell surface of Neisseria meningitidis
Zostect
• INN: Zoster Vaccine
• Indications: prevent herpes zoster (shingles) in adults 50 years and older.
• Type: Recombinant
• Mechanism of Action: works by using a recombinant glycoprotein E, a protein found on the varicella-zoster virus (VZV), the virus that causes shingles.
Adalix
• INN: adalimumab
• Indications: Rheumatoid arthritis, Axial spondyloarthritis, Psoriasis, Psoriatic arthritis, Crohn’s disease, Hidradenitis suppurativa, Ulcerative colitis, Uveitis, Paediatric plaque psoriasis, paediatric Crohn’s disease, paediatric ulcerative colitis, paediatric uveit
• Type: Monoclonal antibody (mAb)
• Mechanism of Action: neutralizes tumor necrosis factor-alpha (TNF-α), a key pro-inflammatory cytokine
Under Registration
DulaGlyx
• INN: Dulaglutide
• Indications: Treatment of type 2 diabetes mellitus in adults as an adjunct to diet and exercise to improve glycemic control.
• Type: Recombinant
• Mechanism of Action: Dulaglutide is a GLP-1 receptor agonist that enhances insulin secretion and suppresses glucagon release, improving glycemic control in adults with type 2 diabetes.
Erenix
• INN: Erenumab
• Indications: Preventive treatment of migraine in adults • Type: Monoclonal antibody (mAb)
• Mechanism of Action: inhibits the action of CGRP, a neuropeptide involved in migraine pathophysiology, thereby reducing the frequency and severity of migraine episodes.
Melanix
• INN : Ipilimumab
• Indications : Treatment of advanced melanoma, a type of skin cancer
• Type: Monoclonal antibody (mAb)
• Mechanism of Action: By blocking CTLA-4, Ipilimumab effectively “releases the brake,” enhancing the body’s immune response against tumor cells.
UsteFlex
• INN: Ustekinumab
• Indications: treatment of moderate to severe plaque psoriasis in adults who are candidates for phototherapy or systemic therapy
• Type: Monoclonal antibody (mAb)
• Mechanism of Action: Inhibits the action of IL-12 and IL-23, which are key mediators in the inflammatory processes of psoriasis, psoriatic arthritis, and Crohn’s disease.
